barri
rous
scott
n
mueller
virus
oblig
intracellular
parasit
requir
host
replic
facilit
spread
other
human
clinic
relev
infect
deriv
anim
process
continu
recent
exampl
includ
human
immunodefici
viru
hiv
ebola
viru
sever
acut
respiratori
syndrom
sar
viru
zika
viru
viral
infect
rare
lethal
even
highli
cytolyt
individu
cell
mortal
commonli
occur
virus
jump
speci
viru
undergo
major
antigen
chang
ie
influenza
virus
host
immun
compromis
hiv
chapter
repres
one
dramat
human
exampl
exot
viru
kill
host
howev
hiv
kill
slowli
provid
ampl
time
spread
new
host
effect
strategi
persist
speci
death
dire
consequ
follow
viru
infect
mammal
inadequ
immun
well
illustr
observ
fetus
neonat
especi
depriv
passiv
immun
succumb
mani
agent
well
toler
healthi
adult
scienc
viral
immunolog
seek
understand
mechan
virushost
interact
view
appli
knowledg
design
effect
vaccin
immunomodul
control
viru
infect
object
facilit
increas
wealth
immunolog
techniqu
expand
array
genet
manipul
anim
model
abund
high
throughput
technolog
gener
data
subject
complex
comput
analysi
analys
yield
signatur
indic
optim
immunogen
vaccin
efficaci
failur
explain
variabl
outcom
infect
individu
host
situat
defens
virus
involv
multipl
immun
compon
impact
singl
mechan
vari
greatli
accord
method
individu
virus
enter
replic
spread
within
host
chapter
highlight
princip
mean
host
achiev
immun
infect
virus
access
target
tissu
present
numer
obstacl
entri
infect
human
virus
effect
mechan
barrier
provid
skin
mucos
surfac
well
chemic
hostil
environ
gut
fig
number
common
human
viral
pathogen
enter
gastrointestin
tract
includ
rotaviru
enter
adenovirus
hepat
viru
hav
usual
spread
via
persontoperson
contact
contamin
food
water
respiratori
infect
caus
influenza
virus
rhinovirus
coronavirus
measl
viru
varicellazost
viru
vzv
respiratori
syncyti
viru
rsv
often
spread
aerosol
transmiss
well
persontoperson
contact
mani
herp
virus
target
skin
mucosa
herp
simplex
viru
hsv
vzv
hsv
particular
infect
oral
genit
mucosa
eye
skin
small
cut
abras
herp
virus
epsteinbarr
viru
ebv
cytomegaloviru
cmv
target
mucosa
cmv
also
spread
vertic
mother
babi
rare
via
blood
transfus
human
papillomaviru
hpv
target
skin
mucosa
caus
wart
may
transform
cell
induc
cancer
cervic
cancer
virus
west
nile
viru
dengu
viru
semliki
forest
viru
zika
viru
enter
skin
via
insect
vector
hiv
hepat
b
viru
hbv
commonli
spread
via
sexual
contact
hiv
hbv
hepat
c
viru
hcv
also
infect
human
direct
entri
bloodstream
via
transfus
contamin
needl
human
virus
replic
certain
target
tissu
mainli
consequ
viral
receptor
distribut
mani
virus
use
two
receptor
use
coreceptor
chemokin
receptor
cell
hiv
attach
cellular
receptor
virus
may
fuse
cell
membran
endocytos
gain
entri
cytoplasm
nucleu
fuse
vesicular
membran
envelop
virus
hsv
hiv
transloc
across
cell
membran
induc
lysi
endocyt
vesicl
cytoplasm
nonenvelop
virus
norwalk
viru
polioviru
virus
util
host
cell
machineri
special
viral
encod
protein
replic
rapidli
within
cell
multipli
within
cell
mani
virus
induc
cytolysi
facilit
releas
new
infecti
virion
eg
poxvirus
polioviru
herp
virus
virus
releas
infect
cell
bud
cell
membran
absenc
cell
death
eg
hiv
influenza
viru
enter
bodi
howev
virus
encount
numer
innat
defens
activ
compon
adapt
immun
latter
usual
assur
clinic
diseas
infect
becom
evid
success
exploit
defens
use
vaccin
chapter
remain
central
challeng
mani
human
virus
particularli
caus
chronic
infect
hiv
hcv
viral
infect
induc
extens
array
defens
mechan
host
innat
defens
come
play
block
inhibit
initi
infect
protect
cell
infect
elimin
virusinfect
cell
innat
mechan
occur
well
effector
adapt
immun
becom
activ
critic
initi
adapt
immun
via
elicit
inflamm
promot
immun
cell
activ
innat
immun
defens
initi
via
pattern
recognit
receptor
prr
recogn
pathogenassoci
molecular
pattern
pamp
chapter
includ
transmembran
receptor
tolllik
receptor
tlr
famili
two
famili
intracellular
receptor
includ
nodlik
receptor
nlr
rigilik
helicas
rlh
well
sensor
molecul
absent
addit
molecul
cyclic
guanosin
monophosphateadenosin
monophosph
gmpamp
synthas
cga
zdnabind
protein
sens
cytosol
dna
tabl
cellular
sensor
promot
express
type
interferon
ifni
varieti
ifnstimul
gene
inflammatori
cytokin
chemokin
tlr
cell
surfac
endosom
membranebound
protein
express
numer
cell
includ
dendrit
cell
dc
macrophag
lymphocyt
parenchym
cell
express
tlr
larg
induc
cell
type
although
constitut
express
high
level
special
plasmacytoid
dc
rapid
ifn
product
differ
tlr
molecul
recogn
specif
viral
product
singleand
doublestrand
rna
tlr
respect
doublestrand
dna
rlh
retino
acidinduc
gene
rigi
melanoma
differentiationassoci
gene
mediat
cytoplasm
recognit
viral
nucleic
acid
activ
mitochondri
antivir
signal
mav
protein
stimul
ifni
product
activ
inflammasom
molecular
complex
facilit
activ
caspas
induc
product
proinflammatori
nlr
second
class
cytosol
sensor
pamp
activ
inflammasom
via
adapt
protein
asc
includ
nlrp
nalp
nod
ipafnaip
receptor
three
major
inflammasom
shown
involv
antivir
immun
inflammasom
rigi
inflammasom
inflammasom
innat
defens
system
consist
multipl
cellular
compon
mani
special
protein
longest
known
beststudi
antivir
protein
ifn
act
bind
type
ifn
receptor
result
transcript
ifnstimul
gene
one
consequ
antivir
state
inhibit
cell
protein
synthesi
prevent
viral
replic
multipl
leukocyt
subset
involv
innat
defens
includ
macrophag
dc
neutrophil
natur
killer
nk
cell
natur
killer
cell
nkt
cell
cell
furthermor
tissu
cell
includ
fibroblast
epitheli
cell
endotheli
cell
express
prr
respond
viral
infect
via
product
innat
cytokin
includ
ifni
ifni
critic
link
innat
adapt
immun
system
via
activ
dc
cell
well
protect
cell
nk
cellmedi
attack
ifni
also
activ
nk
cell
induc
cytokin
promot
prr
cytokin
ifni
ili
phagocyt
includ
macrophag
monocyt
dc
serv
shape
natur
effect
subsequ
adapt
respons
viral
pathogen
instanc
dc
requir
innat
signal
ifni
matur
optim
tcell
activ
furthermor
cell
respond
virus
need
ifni
signal
expans
memori
format
thu
magnitud
type
innat
respons
induc
viru
infect
mark
influenc
gener
adapt
immun
respons
innat
immun
gener
slow
rather
stop
viral
infect
allow
time
adapt
immun
respons
begin
two
major
divis
adapt
immun
antibodymedi
tcellmedi
mainli
direct
differ
target
antibodi
usual
function
bind
free
viral
particl
block
infect
host
cell
chapter
contrast
cell
act
princip
recogn
destroy
virusinfect
cell
orchestr
inflammatori
respons
includ
sever
antivir
compon
chapter
virus
replic
within
cell
mani
spread
directli
cell
without
reenter
extracellular
environ
resolut
infect
reliant
tcell
function
antibodi
function
howev
broadli
neutral
antivir
antibodi
potenti
effect
therapi
mani
differ
human
infect
includ
hiv
influenza
virus
ebola
viru
recent
advanc
allow
research
isol
identifi
human
monoclon
antibodi
mab
pathogen
offer
promis
new
therapi
well
signific
insight
vaccin
design
antivir
antibodi
also
import
immunoprotect
barrier
reinfect
presenc
antibodi
portal
entrymost
often
mucos
surfacesthat
particular
relev
influenza
hsv
hiv
infect
yet
gener
vaccin
induc
optim
antibodi
respons
includ
broadli
neutral
antibodi
remain
import
unsolv
problem
initi
adapt
immun
close
depend
earli
innat
mechan
activ
antigenpres
cell
apc
princip
subset
dc
apc
lymphocyt
drawn
lymphoid
tissu
chemokin
cytokin
signal
retain
day
facilit
effect
intercellular
interact
architectur
secondari
lymphoid
tissu
support
coordin
interact
among
cell
adapt
immun
system
network
support
stromal
cell
local
chemokin
gradient
chapter
induct
event
occur
lymph
node
drain
infect
site
spleen
viru
enter
bloodstream
passag
viral
antigen
lymph
node
usual
occur
dc
virus
abl
compromis
function
apc
hsv
measl
viru
inhibit
dc
matur
bcell
activ
occur
follow
antigen
encount
bcell
follicl
possibl
tcell
zone
spleen
lymph
node
activ
b
cell
becom
shortliv
plasma
cell
wherea
other
move
edg
bcell
follicl
interact
antigenspecif
helper
cell
via
present
antigen
peptid
bcell
mhc
class
ii
molecul
follicular
helper
tfh
cell
special
provid
help
bcell
respons
need
promot
regul
bcell
respons
activ
b
cell
initi
germin
center
gc
reaction
help
tfh
cell
ensur
nk
respons
nk
cell
produc
proinflammatori
cytokin
kill
infect
cell
interact
dc
import
compon
innat
defens
virus
nk
cell
protect
herp
virus
downregul
major
histocompat
complex
mhc
express
cell
infect
nk
cell
also
import
resist
mous
human
cmv
possibl
hiv
influenza
viru
ebola
viru
nk
cell
also
recent
shown
possess
trait
adapt
immun
like
b
cell
form
popul
memori
cell
nk
cell
regul
array
activ
inhibitori
receptor
whose
express
function
begin
understood
uninfect
cell
usual
protect
nk
cell
cytolysi
deliv
neg
signal
high
express
mhc
molecul
contrast
virusinfect
cell
kill
either
deliv
posit
signal
lack
adequ
mhcneg
signal
nk
cell
may
also
control
excess
immun
respons
virus
kill
cell
indirectli
regul
cytotox
lymphocyt
ctl
respons
nkt
cell
may
provid
antigenspecif
innat
immun
protect
certain
virus
influenza
viru
sever
class
innat
host
protein
function
antivir
defens
includ
natur
antibodi
may
play
role
defens
viral
infect
well
pentraxin
complement
protein
virus
may
directli
inactiv
complement
activ
destroy
phagocyt
cell
bind
ingest
complementbound
virion
sever
proinflammatori
cytokin
chemokin
induc
viru
infect
also
play
key
role
defens
foremost
among
member
famili
includ
cytokin
influenc
innat
adapt
immun
cell
play
critic
role
antivir
defens
antivir
cytokin
produc
earli
follow
infect
chemokin
particular
potent
induc
nk
cell
inflammatori
chemokin
may
also
play
import
role
innat
antivir
defens
orchestr
macrophag
neutrophil
dc
nk
cell
respons
site
infect
compon
innat
immun
involv
mediat
initi
protect
virus
sever
compon
eg
act
block
infect
natur
antibodi
complement
compon
cytokin
chemokin
act
protect
cell
infect
act
destroy
inhibit
virusinfect
cell
natur
killer
nk
cell
natur
killer
cell
nkt
cell
macrophag
neutrophil
cell
nitric
oxid
involv
regul
antivir
inflammatori
respons
transform
growth
factor
tgf
chemokin
like
bcell
respons
tcell
respons
viral
infect
also
begin
within
lymphoid
tissu
specif
ctl
precursor
recogn
antigen
context
mhc
class
ipeptid
antigen
complex
dc
cell
becom
activ
prolifer
differenti
effector
expans
antigenspecif
precursor
consider
often
exceed
result
effector
popul
account
host
total
tcell
popul
fig
variou
factor
includ
antigen
apc
costimulatori
molecul
eg
inflammatori
cytokin
eg
ifni
requir
program
develop
function
effector
lymphocyt
infect
tcell
help
also
import
prime
robust
ctl
respons
via
signal
includ
deliv
dc
activ
ctl
effector
exit
lymphoid
organ
access
almost
bodi
locat
via
bloodstream
howev
effector
stay
activ
long
viru
clear
approxim
die
process
term
activationinduc
cell
death
somat
hypermut
affin
matur
select
highaffin
antibodyproduc
longliv
plasma
cell
well
memori
b
cell
molecular
level
upregul
transcript
factor
dictat
plasma
cell
format
wherea
express
delin
b
cell
destin
gc
reaction
memori
bcell
lineag
antibodi
bind
epitop
express
nativ
protein
surfac
free
virion
usual
block
viral
attach
penetr
target
cell
sometim
consequ
viral
lysi
complement
protein
also
involv
opson
sensit
destruct
fc
receptorbear
cell
mediat
antibodydepend
cellular
cytotox
adcc
occasion
howev
fc
receptor
bind
antibodybound
viru
may
facilit
infect
result
sever
tissu
damag
occur
dengu
fever
may
happen
instanc
hiv
infect
antibodi
involv
protect
mucos
surfac
human
predominantli
secretori
immunoglobulin
iga
serumderiv
igg
may
also
protect
particularli
site
vagin
mucosa
antibodi
isotyp
act
mainli
block
infect
epitheli
cell
although
instanc
antibodi
may
transport
antigen
within
bodi
across
epitheli
cell
outsid
mucos
antibodi
persist
much
shorter
period
compar
serum
antibodi
explain
part
immun
mucos
pathogen
usual
much
shorter
durat
compar
immun
system
viral
infect
immunolog
memori
cardin
featur
adapt
immun
goal
vaccinolog
induc
longliv
immunolog
memori
protect
reinfect
chapter
follow
infect
certain
virus
memori
except
longliv
potenti
life
host
eg
yellow
fever
smallpox
virus
memori
defin
persist
specif
lymphocyt
antibodyproduc
plasma
cell
rather
antigen
induc
continu
lymphocyt
activ
humor
memori
virus
involv
longliv
plasma
cell
bone
marrow
provid
continu
lowlevel
sourc
serum
antibodi
mainten
humor
immun
also
involv
popul
homeostat
maintain
memori
b
cell
may
requir
maintain
stabl
number
longliv
plasma
cell
time
pool
memori
cell
regul
lowlevel
homeostat
divis
control
cytokin
memori
cell
primarili
import
surviv
wherea
crucial
lowlevel
prolifer
maintain
size
memori
tcell
pool
immunolog
memori
defin
pool
antigenspecif
cell
whose
increas
frequenc
enabl
rapid
control
viral
reinfect
see
fig
effector
cell
precursor
memori
pool
popul
cell
constitut
effector
pool
preferenti
follow
contract
phase
remain
cell
differenti
memori
cell
remain
less
stabl
popul
host
mani
year
repres
expand
pool
ctl
precursor
activ
upon
secondari
encount
antigen
provid
enhanc
protect
upon
reinfect
viru
see
next
section
although
much
knowledg
tcell
respons
virus
obtain
murin
studi
increasingli
clear
fundament
principl
similar
human
tcell
immun
particular
viru
involv
tcell
subset
recogn
peptid
deriv
viral
antigen
bound
surfac
mhc
protein
class
ii
class
respect
chapter
complex
viral
peptid
bound
mhc
class
ii
protein
gener
apc
scaveng
process
virusinfect
cell
viral
particl
antigenmhc
class
complex
express
surfac
infect
cell
antigen
also
transfer
apc
infect
cell
process
known
crosspresent
recent
experi
mice
also
demonstr
role
transfer
antigen
dc
migrat
infect
tissu
lymphoid
tissu
multipl
subset
dc
exist
special
somewhat
antigen
present
mhci
mhcii
process
activ
cell
receiv
signal
multipl
dc
type
tempor
control
sequenc
coordin
tcell
interact
use
mhc
class
class
ii
tetram
directli
visual
antigenspecif
tcell
respons
respect
demonstr
signific
size
tcell
respons
virus
major
activ
cell
seen
peak
respons
virusspecif
ctl
function
recogn
virusinfect
cell
kill
often
involv
perforin
cytotox
granul
contain
granzym
effector
ctl
also
induc
death
target
cell
follow
engag
fa
ligand
ctl
fa
target
cell
pathway
lead
apoptosi
target
cell
involv
degrad
nucleic
acid
includ
viru
altern
cell
also
mediat
defens
releas
variou
cytokin
antigen
recognit
cytokin
chemokin
highli
produc
ctl
includ
rant
chapter
cytokin
multipl
antivir
effect
infect
cell
cell
around
includ
purg
viru
infect
cell
without
kill
cell
particularli
import
virus
hsv
infect
nonrejuven
cell
nerv
cell
cell
involv
antivir
defens
well
modul
inflammatori
reaction
virus
multipl
function
subset
cell
recogn
base
larg
type
cytokin
produc
recogn
antigen
cell
broadli
reactiv
cell
recogn
larger
peptid
process
viral
protein
restrict
mhc
class
ii
cell
particip
antivir
immun
sever
way
act
helper
cell
develop
highaffin
antibodi
respons
function
tcell
respons
addit
cell
act
effector
orchestr
inflammatori
reaction
either
serv
protect
function
case
becom
prolong
caus
chronic
tissu
damag
chapter
latter
happen
hcvmediat
hepat
hsvmediat
stromal
kerat
occasion
cell
mediat
direct
cytotox
less
effect
cell
princip
subset
cell
involv
inflammatori
reaction
cell
produc
mainli
mani
human
viral
infect
success
control
immun
system
certain
emerg
virus
may
overwhelm
immun
system
caus
sever
morbid
mortal
virus
develop
mechan
overwhelm
evad
immun
system
persist
individu
defect
innat
adapt
immun
demonstr
sever
viral
infect
tcell
immun
import
control
antibodi
mani
viral
infect
antibodi
import
minim
reinfect
particularli
mucos
site
immun
memori
often
suffici
prevent
secondari
diseas
although
viral
infect
tissuespecif
immun
memori
may
import
rapidli
protect
reinfect
peripher
site
eg
skin
mucosa
rm
cell
trigger
enhanc
earli
inflamm
drive
local
immun
contrast
em
cell
continu
migrat
nonlymphoid
tissu
rather
sequest
peripher
tissu
also
differ
cm
migrat
larg
lymphoid
organ
spleen
lymph
node
differ
may
defin
physiolog
raison
memori
tcell
subset
highlight
measur
memori
cell
human
peripher
blood
poor
represent
totalbodi
memori
cell
pool
rm
cell
detect
tissu
use
marker
although
imperfect
identifi
includ
human
tissu
rm
cell
differ
anatom
locat
share
common
genet
signatur
requir
common
transcript
factor
format
yet
cell
also
adopt
uniqu
gene
express
imprint
tissu
environ
presum
impart
special
function
rm
cell
locat
howev
memori
certain
peripher
tissu
lung
appear
wane
time
suggest
memori
cell
may
persist
suffici
number
site
ration
need
vaccin
induc
optim
number
memori
cell
tissu
well
blood
mani
virus
employ
immun
blunt
delay
tactic
circumv
aspect
immun
system
allow
time
replic
escap
detect
tabl
one
mechan
may
involv
kill
infect
apc
virus
may
also
delay
prevent
apoptosi
induc
ctl
within
infect
cell
viral
evas
measur
aim
cellmedi
antivir
defens
system
inhibit
antigen
process
therebi
minim
effector
ctl
induct
escap
ctl
kill
mani
virus
also
downregul
mhc
molecul
surfac
infect
cell
addit
virus
may
produc
variou
mimic
modulatorsinhibitor
cytokin
chemokin
surviv
contract
phase
gradual
differenti
stabl
memori
popul
upon
reinfect
memori
cell
rapidli
activ
virtu
increas
frequenc
mediat
rapid
clearanc
viral
pathogen
moreov
repeat
stimul
memori
cell
via
multipl
infect
viru
primeboost
vaccin
regim
increas
size
antigenspecif
memori
tcell
pool
restimul
also
affect
activ
statu
tissu
distribut
memori
cell
may
enhanc
protect
viral
infect
mucos
tissu
experi
human
mice
demonstr
memori
cell
heterogen
memori
cell
divid
effector
memori
em
central
memori
cm
subset
defin
express
two
surfac
molecul
involv
tcell
migrat
lo
lo
em
subset
found
primarili
nonlymphoid
tissu
spleen
wherea
hi
hi
cm
subset
larg
present
lymph
node
spleen
current
model
predict
effector
cell
form
em
subset
cell
gradual
convert
cm
phenotyp
time
fig
although
condit
control
rate
convers
unknown
like
amount
antigen
inflammatori
signal
receiv
effector
phase
greatli
influenc
also
shown
tcell
help
requir
gener
longliv
memori
cell
via
interact
dc
studi
suggest
cm
capabl
mount
stronger
prolif
respons
follow
reinfect
tissuespecif
home
em
cell
permit
enter
site
potenti
viral
infect
skin
mucosa
howev
know
mani
memori
cell
found
site
previou
viral
infect
take
longterm
resid
tissu
includ
skin
intestin
lung
liver
brain
resid
memori
cell
rm
cell
sequest
circul
provid
rapid
protect
virus
hsv
skin
local
uniqu
dendrit
morpholog
undergo
slow
surveil
tissu
fig
notabl
activ
exhaust
cell
studi
implic
multipl
inhibitori
receptor
potenti
therapeut
target
although
combin
checkpoint
inhibitor
blockad
therapi
prove
highli
benefici
treatment
certain
cancer
similarli
efficaci
respons
yet
demonstr
chronic
viru
infect
typic
individu
human
respond
viru
infect
differ
way
common
cold
even
pandem
influenza
infect
occur
small
percentag
expos
person
may
develop
overt
clinic
diseas
prevaccin
day
poliomyel
muchfear
consequ
polioviru
infect
small
percentag
infect
person
develop
paralyz
complic
similarli
unfortun
develop
lifethreaten
meningoenceph
follow
infect
insecttransmit
west
nile
viru
particularli
characterist
chronic
viral
infect
clinic
express
highli
variabl
hcv
exampl
patient
form
chronic
liver
diseas
develop
viru
clear
howev
infect
control
viru
clear
immun
reinfect
develop
latter
group
individu
make
type
immun
respons
includ
protect
antibodi
along
appropri
pattern
tcell
respons
fulli
understand
reason
vari
outcom
viru
infect
differ
person
almost
certainli
multipl
factor
involv
mani
factor
impact
respons
pattern
made
innat
immun
system
turn
affect
magnitud
type
adapt
immun
respons
occur
circumst
influenc
outcom
infect
includ
genet
suscept
host
age
host
infect
dose
rout
infect
variabl
induct
host
antiinflammatori
cell
protein
presenc
concurr
infect
past
exposur
crossreact
antigen
immun
respons
virusinfect
cell
often
result
tissu
damag
especi
cell
kill
involv
extens
recruit
activ
inflammatori
cell
type
macrophag
sometim
neutrophil
respons
brief
quickli
repair
usual
deem
immunoprotect
event
prolong
tissuedamag
effect
result
immun
reaction
virus
consid
immunopatholog
situat
commonli
involv
persist
virus
often
mildli
cytodestruct
absenc
immun
reaction
chronic
tissu
damag
initi
virus
also
result
develop
autoreact
occasion
oncogen
respons
exampl
autoimmun
diseas
may
initi
exacerb
viral
infect
name
viru
regularli
incrimin
caus
human
autoimmun
diseas
circumstanti
evid
exist
viru
link
multipl
sclerosi
ms
insulindepend
diabet
possibl
system
lupu
erythematosu
sle
ms
mani
virus
isol
patient
although
specif
one
tie
diseas
etiolog
current
hypothesi
viral
infect
set
compon
immun
system
receptor
virus
also
resort
antigen
hypervari
escap
antibodi
tcell
recognit
occur
transmiss
host
host
eg
influenza
viru
within
host
chronic
infect
gener
viral
escap
mutant
latter
particularli
import
hiv
hcv
infect
success
mani
viral
pathogen
rest
abil
subvert
host
immun
respons
success
human
virus
escap
immun
system
persist
life
host
two
wellstudi
exampl
cmv
ebv
tcell
respons
virus
promin
readili
detect
human
yet
immun
system
unabl
clear
either
pathogen
complet
howev
virus
gener
remain
undetect
immunocompet
individu
viral
infect
caus
herp
virus
hsv
vzv
mark
period
latenc
viru
detect
yet
period
viral
reactiv
often
trigger
stress
lead
episod
diseas
control
immun
respons
play
central
role
control
herp
viru
latenc
mani
medic
import
human
virus
associ
persist
viremia
includ
caus
chronic
infect
hiv
hcv
hbv
human
tlymphotrop
viru
htlv
among
other
chronic
viral
infect
mark
high
level
persist
antigen
result
skew
tcell
immunodomin
hierarchi
alter
tissu
local
immun
cell
sever
impair
tcell
function
alter
tcell
function
hierarch
result
function
tcell
defect
rang
reduc
cytokin
product
alter
prolif
capac
exhaust
death
delet
respond
cell
fig
sustain
viral
antigen
level
inflamm
respons
immun
dysfunct
stark
contrast
normal
memori
tcell
develop
occur
absenc
persist
antigen
see
previou
section
studi
demonstr
signal
multipl
inhibitori
receptor
express
cell
surfac
contribut
exhaust
chronic
infect
includ
receptor
program
death
pd
express
may
essenti
prevent
excess
immunopatholog
effector
cell
yet
appear
contribut
directli
fail
immun
hiv
infect
chronic
human
viral
infect
although
molecular
mechan
exhaust
remain
unclear
differenti
involv
transcript
factor
alter
gene
express
defin
immunopatholog
reaction
virus
also
involv
subset
cell
either
one
wellstudi
exampl
involv
persist
infect
theiler
viru
mice
infect
caus
demyelin
syndrom
resembl
autoimmun
diseas
experiment
allerg
encephalomyel
situat
cell
produc
cytokin
appear
serv
patholog
mediat
furthermor
model
increas
involv
myelinderiv
autoantigen
occur
diseas
progress
observ
indic
possibl
role
viru
autoimmun
diseas
theiler
viru
model
viru
persist
nervou
system
chronic
stimul
cell
secret
array
cytokin
demyelin
event
appear
result
cytokin
action
oligodendrocyt
myelin
compon
myelin
basic
protein
proteolipid
protein
myelin
oligodendrogli
glycoprotein
may
releas
particip
addit
antigen
immunoinflammatori
event
scenario
refer
epitop
spread
anoth
model
virusinduc
immunopatholog
mainli
involv
subset
cell
stromal
kerat
caus
hsv
infect
fig
pathogenesi
immunopatholog
lesion
unusu
occur
progress
viral
antigen
longer
demonstr
chronic
immunoinflammatori
lesion
mainli
orchestr
cell
multipl
earli
event
induc
subsequ
inflammatori
environ
may
exacerb
tip
balanc
toward
diseas
genet
suscept
individu
immunopatholog
reaction
involv
virus
sever
mechan
cell
usual
involv
orchestr
inflammatori
event
tabl
clearest
exampl
immunopatholog
involv
viru
lymphocyt
choriomening
viru
lcmv
mous
model
domin
idea
set
sever
paradigm
viral
immunolog
gener
first
virusinduc
immunopatholog
lesion
recogn
glomerulonephr
arter
note
mice
persist
infect
lcmv
lesion
assum
repres
inflammatori
reaction
tissueentrap
immun
complex
activ
complement
similar
immun
complexmedi
lesion
occur
infect
includ
lung
lesion
found
sever
influenza
respiratori
syncyti
viru
infect
viral
hepat
arthriti
howev
rare
viral
antigen
shown
contribut
antigen
compon
complex
exampl
inclus
viral
antigen
immun
complex
demonstr
chronic
hbv
infect
human
autoimmun
diseas
sle
also
result
immun
complexmedi
tissu
damag
howev
evid
link
virus
etiolog
pathogenesi
sle
scarc
sinc
immun
complex
sle
appear
includ
viral
antigen
stage
thank
larg
lcmv
model
clear
tcell
recognit
viral
antigen
result
tissu
damag
lcmv
infect
damag
occur
leptomening
immunocompet
mice
infect
intracerebr
hepat
also
occur
mice
infect
intraven
neither
lesion
becom
evid
tcell
respons
suppress
cellmedi
immunopatholog
caus
mechan
chronic
hepat
associ
hcv
hbv
infect
although
tissu
damag
also
involv
inflammatori
cell
addit
viral
immunopatholog
model
lesion
result
primarili
tcell
involv
includ
myocard
insulindepend
diabet
associ
coxsacki
b
viru
infect
instanc
cell
mainli
orchestr
event
tissu
damag
may
result
bystand
effect
cytokin
molecul
lipid
mediat
biolog
approach
expect
result
novel
screen
immun
protect
paramet
vaccin
near
futur
also
assist
formul
new
vaccin
contain
key
immun
activ
stimul
certain
subset
cell
induc
appropri
home
molecul
express
cell
direct
tissu
requir
mediat
protect
eg
mucos
site
skin
individu
viral
infect
caus
mild
sometim
debilit
tissu
damag
factor
influenc
whether
viral
infect
result
immunopatholog
vari
individu
individu
factor
includ
age
rout
infect
preexist
immun
host
genet
host
viral
burden
virom
knowledg
influenc
factor
outcom
viral
infect
expect
improv
rapidli
come
decad
recent
advanc
shed
consider
light
variou
proinflammatori
antiinflammatori
mediat
produc
viral
infect
repres
key
target
novel
therapi
near
futur
via
use
smallmolecul
inhibitor
human
infect
mani
pathogen
virus
case
infect
control
immun
system
limit
damag
host
howev
certain
virus
particularli
case
host
immun
system
impair
caus
signific
damag
host
tissu
understand
mechan
underli
innat
immun
defens
antigen
present
tand
bcell
respons
treg
continu
improv
abil
design
better
vaccin
therapi
boost
immun
control
viral
infect
although
remain
challeng
goal
particularli
mani
human
virus
hiv
hcv
hsv
rapid
advanc
continu
provid
mani
avenu
investig
patholog
viral
replic
product
certain
cytokin
chemokin
recruit
inflammatori
cell
eg
neutrophil
neovascular
avascular
cornea
preced
immunopatholog
recent
becom
evid
cell
particip
stromal
kerat
lesion
role
cell
orchestr
inflammatori
reaction
major
research
focu
especi
lesion
autoimmun
diseas
cell
princip
mediat
tissu
damag
abund
neutrophil
recruit
inflammatori
site
cell
mainli
respons
tissu
damag
mechan
viralinduc
immunopatholog
autoimmun
molecular
mimicri
molecular
mimicri
repres
share
antigen
epitop
either
bor
tcell
antigen
host
viru
concept
origin
streptococci
associ
rheumat
fever
human
autoimmun
diseas
littl
direct
support
viral
molecular
mimicri
howev
anim
model
use
prove
theoret
case
viral
antigen
express
selfprotein
islet
cell
pancrea
model
subsequ
infect
viru
induc
diabet
howev
true
mimicri
may
close
relat
viral
antigen
persist
model
theiler
diseas
discuss
previous
outcom
tcell
respons
viru
may
critic
depend
balanc
tcelltyp
respons
thu
tissu
damag
like
sever
prolong
cell
predomin
lesion
becom
milder
may
resolv
balanc
favor
treg
accordingli
therapeut
approach
shift
balanc
cell
trial
revers
tcell
exhaust
patient
suffer
chronic
infect
cancer
key
clinic
target
near
futur
discoveri
multipl
inhibitori
receptor
exhaust
cell
eg
provid
opportun
select
improv
tcell
function
blockad
inhibitori
receptor
may
combin
blockad
immunosuppress
cytokin
eg
enhanc
signal
stimulatori
respons
eg
therapi
well
tradit
antivir
therapi
vaccin
challeng
lie
ahead
determin
combin
inhibitori
stimulatori
signal
need
manipul
differ
diseas
differ
group
patient
design
new
gener
vaccin
target
diseas
hiv
influenza
may
requir
tailormad
solut
patient
respond
poorli
vaccin
respond
improperli
advers
effect
autoimmun
reaction
highthroughput
approach
allow
gener
molecular
signatur
vaccin
infect
system
design
new
vaccin
induc
broadli
neutral
antibodi
design
new
vaccin
induc
tissueresid
circul
memori
tcell
subset
overcom
immun
dysfunct
chronic
viral
infect
success
viral
clearanc
improv
efficaci
vaccin
virus
use
system
biolog
approach
therapi
reduc
immunopatholog
viral
infect
